Pfizer (NYSE: PFE)
Pfizer Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Pfizer Company Info
Pfizer Inc. is a research-based global biopharmaceutical company. It engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
News & Analysis
If You'd Invested $1,000 in Pfizer (PFE) Stock 3 Years Ago, Here's How Much You'd Have Today
Investing is about looking ahead.
Pfizer Just Beat Its Earning Estimates. Is This the Beginning of a Turnaround for the Pharmaceutical Stock?
It was a rare breath of fresh air for shareholders.
2 Beaten-Down Stocks to Buy and Hold
The market has been tough on these stocks, but a closer look at each is warranted.
Meet the 7.3% Yield Dividend Stock That Could Soar in 2026
This stock recently bounced on strong Q2 earnings, and the fun could be just getting started.
Investing in Pharmaceutical Stocks
This 7% Yielding Stock Just Raised Its Profit Forecast. Is It Time to Buy?
Meeting its dividend commitment this year should be a breeze, but the path ahead is much harder to predict.
1 Reason to Buy Pfizer (PFE) Stock
How does $740 in annual income sound?
Why Shares of Pfizer Soared Today
The large pharmaceutical company reported strong second-quarter earnings results.
Valuation
Podcast Episodes
A Coronavirus Vaccine Is Good News. What's Going on With Cruise Lines?
A look at stock market news.
Why Is a Coronavirus Vaccine Bad News for Some Stocks?
Investors knew that a vaccine was coming, so why did the market react the way it did?
Why Coronavirus Vaccine News Is Great for Bank Stocks and REITs
Some of our favorite banks and real estate stocks are having their best rallies in years.
2 Reasons Pfizer Is on Our Minds Today
First, it raised some spinoff speculation. Second, it's in an intriguing tussle with J&J that could affect the biosimilars market for everyone.
Earnings Transcripts
Pfizer (PFE) Q4 2024 Earnings Call Transcript
PFE earnings call for the period ending December 31, 2024.
Pfizer (PFE) Q3 2024 Earnings Call Transcript
PFE earnings call for the period ending September 30, 2024.
Pfizer (PFE) Q2 2024 Earnings Call Transcript
PFE earnings call for the period ending June 30, 2024.
Pfizer (PFE) Q1 2024 Earnings Call Transcript
PFE earnings call for the period ending March 31, 2024.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.